John Markman, MD is a Professor of Neurosurgery and Neurology at the University of Rochester, where he also serves as a Vice Chair, Director of the University’s Translational Pain Research Program, and Chief of the Division of Pain Medicine. Markman has led more than sixty clinical trials of new methods and treatments for chronic pain. The University of Rochester program he founded was recognized by the American Pain Society as the nation’s Academic Center of Excellence in 2013 for its innovative, multidisciplinary patient care. In 2022, Dr. Markman received the Mitchell Max Scientific Award for his contributions to pain research by the American Academy of Neurology. The Academy cited the impact of randomized controlled studies led by Markman in furthering the scientific understanding of the efficacy and safety of treatments for chronic low back pain and for chronic pain resulting from nerve injury. Markman currently directs one of the nation’s 12 NIH HEAL Initiative clinical trial hubs pursuing novel, non-opioid treatments for chronic pain. Over the course of his career Markman has authored more than 100 peer-reviewed publications and served as an editorial board member of the Journal of Pain and Pain Medicine, a member of the FDA's AADP Advisory Committee, an examiner for the American Board of Psychiatry and Neurology, and various leadership roles of professional societies dedicated to the treatment of pain including the International Association for the Study of Pain, The American Pain Society, and The North American Neuromodulation Society. Markman received his MD at the University of Rochester. He completed his training in Neurology at Mass General Brigham and Pain Medicine at Beth Israel Deaconess Medical Center.
- University of Rochester School of Medicine
- Rochester, NY